While high-doses of berberine could induces apoptosis through the AMPK-p53 pathway via mechanism independent of hypoxia-inducible factor 1α (HIF-1α) expression, low doses could sensitise drug-resistance breast cancer cells to doxorubicin via the AMPK-HIF-1α-P-gp pathway. This evidence concerns the gene HIF1A and breast cancer.